ANXA1 and hypertensive disorder: Zhong et al. reported that reducing the expression level of ANXA1 protein and messenger RNA in rats with the hypothalamus of spontaneously hypertensive rats with hyperactivity of liver‐YANG syndrome can effectively control hypertension and improve hyperactivity [51], indicating that ANXA1 may act as a potential therapeutic target for hypertension.